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EXPANSION OF COMMMON MYELOID PROGENITORS IN CHRONIC MY-
ELOMONOCYTIC LEUKEMIA
Jamieson, C.H.M.1,2, Li, K.2, Weissman, I.L.2 1. Division of Hema-
tology, Stanford, CA; 2. Department of Pathology, Stanford, CA
Chronic myelomonocytic leukemia (CMML) is a unique myelo-
proliferative disease characterized by marrow dysplasia and an
increase in monocytes. The median survival of patients with
CMML is short (approximately 2 years), in part, because CMML
is frequently resistant to therapy including allogeneic peripheral
blood progenitor transplantation. In order to reduce regimen re-
lated toxicity and provide more effective CMML targeted thera-
pies, a better understanding of the basic biology of CMML pro-
genitors is required. We used FACS analysis and recently
identiﬁed phenotypic markers to identify phenotypic and func-
tional differences between normal and CMML bone marrow he-
matopoietic stem cells and myeloid progenitors. CMML marrow
was typiﬁed by a reduction in CD34CD38-CD90Lin-hemato-
poietic stem cells and an expansion of CD34CD38-CD90-
Flk2Lin-cells relative to normal bone marrow. In addition, there
was a two-fold expansion in common myeloid progenitors (CMPs)
and a corresponding decrease in megakaryocyte-erythroid progen-
itors (MEPs) suggesting that there was a skew in differentiation
toward the myeloid lineage. In contrast to normal bone marrow
derived CMPs, CMML CMPs gave rise to myeloid but not ery-
throid colonies. Moreover, real time quantitative RT-PCR analysis
of highly puriﬁed FACS-sorted CMML CMPs demonstrated an
increase in expression of two key regulators of myelomonocytic
differentiation, PU.1 and c-jun, compared with normal bone mar-
row. A more detailed understanding of the basic biology of CMML
myeloid progenitors and the genes that work in concert to expand
them may aid in identifying novel molecular targets for CMML
therapy.
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3-DIMENSIONAL MULTI-MODALITY NON-INVASIVE IMAGING OF THE
BONE MARROW ENGRAFTMENT MODEL
Doubrovin, M.1, Mayer-Kuckuk, P.2, Budak-Alpdogan, T.1, Bidaut,
L.1, Cai, S.1, Ponomarev, V.1, Blasberg, R.1, van den Brink, M.1,
Bertino, J.2, Benarjee, D.2, Gelovani, J.3 1. Memorial Sloan-Kettering
Cancer Center, New York, NY; 2. UMDNJ, New Brunswick, NJ; 3.
MD Anderson Cancer Cnter, Houston, TX
The studies of the stem cell biology and engraftment often have
to address the question of the cell homing, migration and local-
ization. We tested feasibility of applying a multi-modality imaging
approach for a non-invasive localization of a genetically modiﬁed
graft. The bone marrow cells of C57BL/6 mice were transduced
using retrovirus bearing hsv-tk/egfp/luc reporter fusion gene, char-
acterized by the GFP expression and the whole bone marrow graft,
including up to 38% GFP-positive cells was transfused to the
lethally irradiated B6.SJL-Ptprc mice. The preliminary informa-
tion on the engraftment and location of the cells over a 4 week
period from the transplant was obtained by bio-luminescent im-
aging (BLI) continuously and the 3-dimentinally resolved data on
the bone-marrow homing were obtained by a combination of
MicroCT and MicroPET using [18F]FEAU as a radiotracer. The
data were conﬁrmed morphologically by GFP microscopy of the
tissue sections. It was also possible to obtain ex vivo biolumines-
cence from the excised organs and tissues incubated with D-
luciferin in vitro. 3-Dimensional reconstruction and processing of
MicroPET and MicroCT images allowed for coregistration of the
major foci of bone marrow transplanted cells within the bone
marrow homing areas. The primary sites of the transplanted cell
targeting were in the epiphyses of the ling bones, spongeous parts
of the skull bones and vertebrae. This analysis allowed differenti-
ating the speciﬁc signal originating from the lumar spine from a
non-speciﬁc radiotracer cleared through the gut. There was a
transient signal noted in the projection of spleen over the second
week post-transplant observed by the BLI. MicroPET images on
days 6 and tissue sample analysis conﬁrmed this ﬁnding. Slightly
decreased radiotracer accumulation discordant to the continuously
increasing BLI signal over the time of observation may denote
speciﬁc changes in susceptibility of the bone marrow cells towards
nucleoside-based radiotracer imaging. MicroCT without contrast
agent appeared to be poorly applicable for soft-tissue imaging, but
crucial for the bone locations. The study proved feasibility of
multi-modality approach for obtaining the information on the
bone-marrow cell localization to speciﬁc organs non-invasively in
live recipients over time combining sensitivity and structural spec-
iﬁcity of different methods. Multiple imaging sessions with intra-
venous administration of the probes were well tolerated by the
animals.
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BOTH TISSUE DERIVED AND BONE MARROW DERIVED STROMAL
CELLS ARE IMMUNOREGULATORY
Kleiner, G.I., Gandia, C., Yu, H., Defaria, W., Santiago, S., Tzakis, A.
University of Miami School of Medicine, Miami, FL
Bone marrow derived mesenchymal stem cells have been dem-
onstrated to have immunosuppressive effects in mice and humans.
These ﬁnding suggest that they may be exploited in organ trans-
plantation settings. Here, we investigated immunoregulatory as-
pects of rat intestinal derived and BM MSCs. Bone marrow was
extracted from six to eight week old DA rats and plated in DMEM
containing 10% Fetal Bovine Serum, 2% L-Glutamine, 1% Pen-
icillin-Streptomycin, and 1% Sodium Pyruvate (Gibco). Every 48
hours, non-adherent cells are discarded. The immunosuppressive
effects of these cells in a allogenic mixed lymphocyte reaction were
investigated. Intestinal derived mesenchymal cells were obtained
by enzymatic (collagenase, dispase) digestion followed by plastic
adherence. Mesenteric lymph nodes from both DA and Lewis rats
were extracted and passed through a metal ﬁlter to extract lym-
phocytes. Irradiated DA lymphocytes were used as stimulators.
Lymphocytes were cultured in IMDM Media containing 1% glu-
tamine, 1% Rat Serum, 1% Non-Essential Amino Acids, 0.1%
Beta-Mercapthanol, 1% Penicillin-Streptomycin, 1% Sodium
Pyruvate, 1% HEPES, and 1% vitamin (Gibco). DA MSCs were
added at gradual concentrations of 105, 104, 103, 102, and 101. After
a four day incubation, 1uCi of tritiated thymidine was added.
Lymphocytes were also cultured with 2 mcg/ml ConA. In MLR
cultures, MSC dramatically suppressed MLR responses (99%)
when added at concentration of 105 MSCs. Suppression was dose
dependent. In ConA cultures, MSC suppression of lymphoid cells
was maximal at 105 cells. MSC suppression was not MHC re-
stricted as Lewis derived MSCs also suppressed MLR and ConA
responses (90%). Intestinal MSCs also suppressed MLR re-
sponses (85%). MSCs suppressed skin graft rejection in an in-
vivo model. The results suggest that BM and tissue derived MSCs
may have clinical utility in transplantation settings.
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COMMON LYMPHOID PROGENITORS REQUIRE COMMON GAMMA (C)
AND C-KIT SIGNALS FOR SURVIVAL IN VIVO
Dudl, E.1, Toyama, A.1, Arber, C.2, BitMansour, A.2, Brown, J.1,
Chung, B.1, Price, M.1, Brown, J.M.Y.2, Weinberg, K.I.1 1. Research
Immunology/ Bone Marrow Transplantation, Childrens Hospital Los
Angeles, Los Angeles, CA; 2. Bone Marrow Transplantation and Infec-
tious Diseases, Stanford University, Stanford, CA
CLP are rare, highly proliferative bone marrow cells which are
committed to T, B, and NK cell maturation, but lack myeloid or
erythroid potential. CLP are phenotypically identiﬁed in marrow
as IL-7R() Lin(-) Sca-1(lo) C-kit(lo) cells. Co-transplantation of
small numbers of CLP in hematopoietic stem cell transplant re-
cipients results in rapid improvements in antigen-speciﬁc immune
function without causing graft-versus-host disease. The mecha-
nisms of CLP survival, proliferation, and development in vivo are
not well understood. Because the IL-7 and c-kit receptors are
simultaneously expressed on CLP, genetic models were used to
determine the role of these two receptor pathways in the mainte-
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